WallStSmart
FBRX

Forte Biosciences Inc

NASDAQ: FBRX · HEALTHCARE · BIOTECHNOLOGY

$28.03
+6.23% today

Updated 2026-04-29

Market cap
$537.90M
P/E ratio
P/S ratio
EPS (TTM)
$-4.71
Dividend yield
52W range
$6 – $36
Volume
0.3M

Forte Biosciences Inc (FBRX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20152016201720182019202020212022202320242025
Revenue$51000.00$49000.00$41000.00$18.04M$36000.00$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)-3.9%-16.3%+43890.2%-99.8%-100.0%
Cost of revenue$11000.00$54000.00$36000.00$9000.00$39000.00$64000.00
Gross profit$51000.00$49000.00$41000.00$18.04M$-11000.00$-54000.00$-36000.00$-9000.00$-39000.00$-64000.00
Gross margin100.0%100.0%100.0%100.0%-30.6%
R&D$19.17M$27.22M$29.11M$50.45M$2.67M$9.95M$13.85M$5.59M$21.86M$21.19M$57.65M
SG&A$3.83M$4.52M$8.56M$265680.00$1.38M$4.22M$7.63M$8.30M$10.62M$15.41M$12.41M
Operating income$-22.95M$-31.69M$-37.63M$-45.85M$-4.06M$-14.22M$-21.49M$-13.90M$-32.49M$-36.60M$-70.66M
Operating margin-45007.8%-64675.5%-91778.0%-254.2%-11288.9%
EBITDA$-22.48M$-31.17M$-36.70M$-43.69M$-4.06M$-46.43M$-21.45M$-13.90M$-32.48M$-35.44M$-70.59M
EBITDA margin-44088.2%-63614.3%-89524.4%-242.3%-11272.2%
EBIT$-22.72M$-31.43M$-37.00M$-44.32M$-4.07M$-46.49M$-21.49M$-13.90M$-32.49M$-35.48M$-70.66M
Interest expense$102000.00$1.84M$1.93M$173380.00$3.82M$0.00$222000.00$17000.00
Income tax$-204000.00$-3.67M$-2.60M$1.70M$-2520.00$32.06M$-200558.00$-17000.00$-35.48M
Effective tax rate0.9%9.9%6.3%-3.6%0.1%-222.2%0.9%0.1%0.0%50.0%0.0%
Net income$-23.06M$-33.48M$-38.93M$-48.95M$-4.07M$-46.49M$-21.71M$-13.86M$-31.48M$-35.48M$-69.38M
Net income growth (YoY)-45.2%-16.3%-25.8%+91.7%-1042.5%+53.3%+36.1%-127.1%-12.7%-95.5%
Profit margin-45207.8%-68322.4%-94948.8%-271.4%-11302.8%